A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2018-07-12
Target enrollment:
Participant gender:
Summary
This study will compare LY900014, a drug that lowers blood sugar, with insulin lispro
(Humalog). Both drugs will be given by injection under the skin of the abdomen. This study
will be conducted in participants with type 1 diabetes to investigate how quickly and how
much LY900014 is absorbed and the effect of LY900014 on blood sugar levels in comparison with
insulin lispro. The study will last about 3 to 6 weeks for each participant, not including
screening.